How Much Upside is Left in Nurix Therapeutics (NRIX)? Wall Street Analysts Think 25.27%

Shares of Nurix Therapeutics, Inc. (NRIX) have gained 3.1% over the past four weeks to close the last trading session at $21.09, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $26.42 indicates a potential upside of 25.3%. The mean estimate comprises 12 short-term price targets with a standard deviation of $5.95. While the lowest estimate of $15 indicates a 28.9% decline from th ...